Sfoglia per Rivista
Peptides for imaging infection and inflammation
2003-01-01 Oyen, W; Boerman, Oc; Rennen, Hjjm; Corstens, Fhm
PET radioimmunoscintigraphy of renal cell cancer using Zr-89-labeled cG250 monoclonal antibody in nude rats
2004-01-01 Brouwers, A; Verel, I; Van Eerd, J; Visser, G; Steffens, M; Oosterwijk, E; Corstens, F; Oyen, W; Van Dongen, G; Boerman, O
Pharmacokinetics and tumor targeting of I-131-labeled F(ab ')(2) fragments of the chimeric monoclonal antibody G250: Preclinical and clinical pilot studies
2004-01-01 Brouwers, A; Mulders, P; Oosterwijk, E; Buijs, W; Corstens, F; Boerman, O; Oyen, W
Pretargeted immunoPET imaging of CEA-expressing tumors using a Ga-68 labeled peptide
2008-01-01 Boerman, Oc; Sharkey, Rm; Chang, Ch; Rossi, Ea; Mcbride, W; Schoffelen, R; Oyen, W; Goldenberg, Dm
Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: Best of both worlds?
2000-01-01 Boerman, Oc; Oyen, W; Corstens, Fhm
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2xAnti-HSG Bispecific Antibody and a Lu-177-Labeled Peptide
2014-01-01 van Rij, Cm; Frielink, C; Goldenberg, Dm; Sharkey, Rm; Lutje, S; Mcbride, W; Oyen, W; Boerman, Oc
Radioimmunoscintigraphy of colorectal cancer using a two-step pre-targeting method
2008-01-01 Aarts, F; Boerman, Oc; Sharkey, Rm; Hendriks, T; Chang, Ch; Mcbride, Wj; Bleichrodt, Rp; Oyen, W; Goldenberg, Dm
Radioimmunotherapy as an adjuvant treatment after cytoreductive surgery is an effective treatment of peritoneal carcinomatosis of colonic origin
2006-01-01 Aarts, F; Koppe, Mj; Hendriks, T; Bleichrodt, Rp; Oyen, W; Boerman, O
Radioimmunotherapy prevents anastomotic relapse of colorectal cancer in a rat model
2008-01-01 de Long, G; Hendriks, T; Oyen, W; Aarts, F; Bleichrodt, Rp; Boerman, Oc
Radioimmunotherapy using I-131-cG250 in patients with metastasized renal cell carcinoma with two consecutive treatments at the maximum tolerated dose
2004-01-01 Brouwers, Ah; Mulders, Pf; de Mulder, Ph; Buijs, Wc; van den Broek, Wj; Mala, C; Oyen, W
Radioimmunotherapy with lutetium-177 labeled monoclonal antibody cG250 in patients with advanced renal cell carcinoma
2008-01-01 Stillebroer, Ab; Oosterwijk, E; Mulders, Pfa; Oyen, W; Boerman, Oc
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250
2006-01-01 Hendrickx, Bw; Punt, Cja; Boerman, Oc; Postema, Ej; Oosterwijk, E; Mavridu, A; Corstens, Fhm; Oyen, W
Tracers to monitor the response to chemotherapy: In vitro screening of four radiopharmaceuticals
2004-01-01 de Geus-Oei, Lf; van Eerd-Vismale, J; Molthoff, C; Corstens, F; Oyen, W; Boerman, O
Tumor Accumulation of Radiolabeled Bevacizumab due to Targeting of Cell- and Matrix-Associated VEGF-A Isoforms
2009-01-01 Stollman, Th; Scheer, Mgw; Franssen, Gm; Verrijp, Kn; Oyen, W; Ruers, Tjm; Leenders, Wpj; Boerman, Oc
Tumor targeting with alpha(v)beta(3) integrin binding peptides
2003-01-01 Boerman, Oc; Oyen, W; Frielink, C; Dijkgraaf, I; Harris, Td; Edwards, Ds; Corstens, Fhm
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile